Skip to main content
See every side of every news story
Published loading...Updated

Federal Agencies Open Investigation Into the Safety of Abortion Drug Mifepristone ✅

The Health and Human Services and FDA are reviewing mifepristone following studies showing nearly 11% of patients reported serious adverse events after using the abortion pill.

  • The Trump administration is reviewing safety protocols surrounding mifepristone amid restrictions from conservative states, as reported by the Hill.
  • Robert F. Kennedy Jr. and FDA Commissioner Marty Makary stated that HHS may change the Risk Evaluation and Mitigation Strategy due to new studies questioning safety.
  • Texas allows private citizens to sue anyone involved in abortion drug transactions for up to $100,000, exempting users of the pills.
  • Attorney General Ken Paxton issued cease-and-desist letters to organizations for allegedly facilitating illegal abortion drug access in Texas.
Insights by Ground AI

63 Articles

WAGAWAGA
+5 Reposted by 5 other sources
Center

RFK Jr. launches FDA safety review of abortion pill mifepristone

The Food and Drug Administration will review the safety of mifepristone, the most widely used abortion drug in the U.S, at the request of Republican-led states.

·Atlanta, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 62% of the sources are Center
62% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

LifeNews.com broke the news in New York, United States on Wednesday, September 24, 2025.
Sources are mostly out of (0)
News
For You
Search
BlindspotLocal